Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca++-ATPase in mammalian ventricle

Bettina Linck, Peter Bokník, Hideo A. Baba, Thomas Eschenhagen, Uta Haverkamp, Elmar Jäckel, Larry Jones, Uwe Kirchhefer, Jörg Knapp, Stephanie Läer, Frank U. Müller, Wilhelm Schmitz, Hasso Scholz, Annemarie Syska, Ute Vahlensieck, Joachim Neumann

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

We studied the influence of prolonged administration of the beta adrenoceptor agonist isoproterenol on contractile parameters and expression of sarcoplasmic reticulum (SR) Ca++-ATPase and phospholamban, genes important for Ca++ uptake into the SR. Isoproterenol (Iso), 0.9% NaCl (Ctr), propranolol (Prop) or Iso plus Prop were administered to rats by subcutaneous infusion with osmotic minipumps for 1,2, 3, 4, 8, 13 and 26 days, respectively. The positive inotropic effect of Iso was impaired in rats pretreated with Iso in vivo. Iso pretreatment shortened time to peak tension (TPT) by 28%, time of relaxation (RT) by 27% and total contraction time (TCT) by 27% compared with the appropriate controls (day 2). The shortening of time-dependent contractile indices started after 1 day of Iso pretreatment, reached a maximum after 2 days and remained reduced for 4 days. Longer treatment by Iso failed to affect time parameters, whereas the positive inotropic effect of Iso added to the isolated muscles persisted. The shortened contractile time parameters were accompanied by diminished mRNA and protein expression of phospholamban (PLB) and SR-Ca++-ATPase (SERCA). The mRNA levels for PLB and SERCA were maximally reduced by 31 ± 1.3% and 41 ± 1.4% in the Isopretreated group (2 days) respectively. The reduced mRNA levels were accompanied by reduced levels of the corresponding proteins. It is concluded that altered levels of PLB and SERCA probably account for the noted changes in contractile time parameters in the mammalian heart.

Original languageEnglish
Pages (from-to)531-538
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume286
Issue number1
StatePublished - Jul 1998

Fingerprint

Sarcoplasmic Reticulum
Isoproterenol
Adrenergic Receptors
Adenosine Triphosphatases
Propranolol
Messenger RNA
phospholamban
Subcutaneous Infusions
Proteins
Muscles

ASJC Scopus subject areas

  • Pharmacology

Cite this

Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca++-ATPase in mammalian ventricle. / Linck, Bettina; Bokník, Peter; Baba, Hideo A.; Eschenhagen, Thomas; Haverkamp, Uta; Jäckel, Elmar; Jones, Larry; Kirchhefer, Uwe; Knapp, Jörg; Läer, Stephanie; Müller, Frank U.; Schmitz, Wilhelm; Scholz, Hasso; Syska, Annemarie; Vahlensieck, Ute; Neumann, Joachim.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 286, No. 1, 07.1998, p. 531-538.

Research output: Contribution to journalArticle

Linck, B, Bokník, P, Baba, HA, Eschenhagen, T, Haverkamp, U, Jäckel, E, Jones, L, Kirchhefer, U, Knapp, J, Läer, S, Müller, FU, Schmitz, W, Scholz, H, Syska, A, Vahlensieck, U & Neumann, J 1998, 'Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca++-ATPase in mammalian ventricle', Journal of Pharmacology and Experimental Therapeutics, vol. 286, no. 1, pp. 531-538.
Linck, Bettina ; Bokník, Peter ; Baba, Hideo A. ; Eschenhagen, Thomas ; Haverkamp, Uta ; Jäckel, Elmar ; Jones, Larry ; Kirchhefer, Uwe ; Knapp, Jörg ; Läer, Stephanie ; Müller, Frank U. ; Schmitz, Wilhelm ; Scholz, Hasso ; Syska, Annemarie ; Vahlensieck, Ute ; Neumann, Joachim. / Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca++-ATPase in mammalian ventricle. In: Journal of Pharmacology and Experimental Therapeutics. 1998 ; Vol. 286, No. 1. pp. 531-538.
@article{8a7aa7fad09a49f7b9ca5567ed6a62f0,
title = "Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca++-ATPase in mammalian ventricle",
abstract = "We studied the influence of prolonged administration of the beta adrenoceptor agonist isoproterenol on contractile parameters and expression of sarcoplasmic reticulum (SR) Ca++-ATPase and phospholamban, genes important for Ca++ uptake into the SR. Isoproterenol (Iso), 0.9{\%} NaCl (Ctr), propranolol (Prop) or Iso plus Prop were administered to rats by subcutaneous infusion with osmotic minipumps for 1,2, 3, 4, 8, 13 and 26 days, respectively. The positive inotropic effect of Iso was impaired in rats pretreated with Iso in vivo. Iso pretreatment shortened time to peak tension (TPT) by 28{\%}, time of relaxation (RT) by 27{\%} and total contraction time (TCT) by 27{\%} compared with the appropriate controls (day 2). The shortening of time-dependent contractile indices started after 1 day of Iso pretreatment, reached a maximum after 2 days and remained reduced for 4 days. Longer treatment by Iso failed to affect time parameters, whereas the positive inotropic effect of Iso added to the isolated muscles persisted. The shortened contractile time parameters were accompanied by diminished mRNA and protein expression of phospholamban (PLB) and SR-Ca++-ATPase (SERCA). The mRNA levels for PLB and SERCA were maximally reduced by 31 ± 1.3{\%} and 41 ± 1.4{\%} in the Isopretreated group (2 days) respectively. The reduced mRNA levels were accompanied by reduced levels of the corresponding proteins. It is concluded that altered levels of PLB and SERCA probably account for the noted changes in contractile time parameters in the mammalian heart.",
author = "Bettina Linck and Peter Bokn{\'i}k and Baba, {Hideo A.} and Thomas Eschenhagen and Uta Haverkamp and Elmar J{\"a}ckel and Larry Jones and Uwe Kirchhefer and J{\"o}rg Knapp and Stephanie L{\"a}er and M{\"u}ller, {Frank U.} and Wilhelm Schmitz and Hasso Scholz and Annemarie Syska and Ute Vahlensieck and Joachim Neumann",
year = "1998",
month = "7",
language = "English",
volume = "286",
pages = "531--538",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca++-ATPase in mammalian ventricle

AU - Linck, Bettina

AU - Bokník, Peter

AU - Baba, Hideo A.

AU - Eschenhagen, Thomas

AU - Haverkamp, Uta

AU - Jäckel, Elmar

AU - Jones, Larry

AU - Kirchhefer, Uwe

AU - Knapp, Jörg

AU - Läer, Stephanie

AU - Müller, Frank U.

AU - Schmitz, Wilhelm

AU - Scholz, Hasso

AU - Syska, Annemarie

AU - Vahlensieck, Ute

AU - Neumann, Joachim

PY - 1998/7

Y1 - 1998/7

N2 - We studied the influence of prolonged administration of the beta adrenoceptor agonist isoproterenol on contractile parameters and expression of sarcoplasmic reticulum (SR) Ca++-ATPase and phospholamban, genes important for Ca++ uptake into the SR. Isoproterenol (Iso), 0.9% NaCl (Ctr), propranolol (Prop) or Iso plus Prop were administered to rats by subcutaneous infusion with osmotic minipumps for 1,2, 3, 4, 8, 13 and 26 days, respectively. The positive inotropic effect of Iso was impaired in rats pretreated with Iso in vivo. Iso pretreatment shortened time to peak tension (TPT) by 28%, time of relaxation (RT) by 27% and total contraction time (TCT) by 27% compared with the appropriate controls (day 2). The shortening of time-dependent contractile indices started after 1 day of Iso pretreatment, reached a maximum after 2 days and remained reduced for 4 days. Longer treatment by Iso failed to affect time parameters, whereas the positive inotropic effect of Iso added to the isolated muscles persisted. The shortened contractile time parameters were accompanied by diminished mRNA and protein expression of phospholamban (PLB) and SR-Ca++-ATPase (SERCA). The mRNA levels for PLB and SERCA were maximally reduced by 31 ± 1.3% and 41 ± 1.4% in the Isopretreated group (2 days) respectively. The reduced mRNA levels were accompanied by reduced levels of the corresponding proteins. It is concluded that altered levels of PLB and SERCA probably account for the noted changes in contractile time parameters in the mammalian heart.

AB - We studied the influence of prolonged administration of the beta adrenoceptor agonist isoproterenol on contractile parameters and expression of sarcoplasmic reticulum (SR) Ca++-ATPase and phospholamban, genes important for Ca++ uptake into the SR. Isoproterenol (Iso), 0.9% NaCl (Ctr), propranolol (Prop) or Iso plus Prop were administered to rats by subcutaneous infusion with osmotic minipumps for 1,2, 3, 4, 8, 13 and 26 days, respectively. The positive inotropic effect of Iso was impaired in rats pretreated with Iso in vivo. Iso pretreatment shortened time to peak tension (TPT) by 28%, time of relaxation (RT) by 27% and total contraction time (TCT) by 27% compared with the appropriate controls (day 2). The shortening of time-dependent contractile indices started after 1 day of Iso pretreatment, reached a maximum after 2 days and remained reduced for 4 days. Longer treatment by Iso failed to affect time parameters, whereas the positive inotropic effect of Iso added to the isolated muscles persisted. The shortened contractile time parameters were accompanied by diminished mRNA and protein expression of phospholamban (PLB) and SR-Ca++-ATPase (SERCA). The mRNA levels for PLB and SERCA were maximally reduced by 31 ± 1.3% and 41 ± 1.4% in the Isopretreated group (2 days) respectively. The reduced mRNA levels were accompanied by reduced levels of the corresponding proteins. It is concluded that altered levels of PLB and SERCA probably account for the noted changes in contractile time parameters in the mammalian heart.

UR - http://www.scopus.com/inward/record.url?scp=14444282890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14444282890&partnerID=8YFLogxK

M3 - Article

C2 - 9655899

AN - SCOPUS:14444282890

VL - 286

SP - 531

EP - 538

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -